Back to Journals » OncoTargets and Therapy » Volume 6

Nimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities

Total article views   HTML views PDF downloads Totals
11,171 Dovepress* 8,643+ 1,770 10,413
PubMed Central* 2,528 1,211 3,739
Totals 11,171 2,981 14,152
*Since 24 July 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar